Author:
Jin Guang,Ho Jessie W.,Keeney-Bonthrone Toby Philip,Pai Manjunath P.,Wen Bo,Ober Rebecca Ariel,Dimonte Deanna,Chtraklin Kiril,Joaquin Theodore Alan,Latif Zoya,Vercruysse Claire,Alam Hasan B.
Abstract
BACKGROUND
It has previously been shown that administration of valproic acid (VPA) can improve outcomes if given within an hour following traumatic brain injury (TBI). This short therapeutic window (TW) limits its use in real-life situations. Based upon its pharmacokinetic data, we hypothesized that TW can be extended to 3 hours if a second dose of VPA is given 8 hours after the initial dose.
METHOD
Yorkshire swine (40–45 kg; n = 10) were subjected to TBI (controlled cortical impact) and 40% blood volume hemorrhage. After 2 hours of shock, they were randomized to either (1) normal saline resuscitation (control) or (2) normal saline–VPA (150 mg/kg × two doses). First dose of VPA was started 3 hours after the TBI, with a second dose 8 hours after the first dose. Neurologic severity scores (range, 0–36) were assessed daily for 14 days, and brain lesion size was measured via magnetic resonance imaging on postinjury day 3.
RESULTS
Hemodynamic and laboratory parameters of shock were similar in both groups. Valproic acid–treated animals had significantly less neurologic impairment on days 2 (16.3 ± 2.0 vs. 7.3 ± 2.8) and 3 (10.9 ± 3.6 vs. 2.8 ± 1.1) postinjury and returned to baseline levels 54% faster. Magnetic resonance imaging showed no differences in brain lesion size on day 3. Pharmacokinetic data confirmed neuroprotective levels of VPA in the circulation.
CONCLUSION
This is the first study to demonstrate that VPA can be neuroprotective even when given 3 hours after TBI. This expanded TW has significant implications for the design of the clinical trial.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Critical Care and Intensive Care Medicine,Surgery
Reference37 articles.
1. Death on the battlefield (2001–2011): implications for the future of combat casualty care;J Trauma Acute Care Surg,2012
2. Estimating the global incidence of traumatic brain injury;J Neurosurg,2018
3. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Neurol,2019
4. Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma;J Trauma Acute Care Surg,2017
5. Dose optimization of valproic acid in a lethal model of traumatic brain injury, hemorrhage, and multiple trauma in swine;J Trauma Acute Care Surg,2019